255 related articles for article (PubMed ID: 36615667)
1. The Importance of Neonatal Screening for Galactosemia.
Badiu Tișa I; Achim AC; Cozma-Petruț A
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615667
[TBL] [Abstract][Full Text] [Related]
2. Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment.
Succoio M; Sacchettini R; Rossi A; Parenti G; Ruoppolo M
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883524
[TBL] [Abstract][Full Text] [Related]
3. GALT Deficiency Galactosemia.
Anderson S
MCN Am J Matern Child Nurs; 2018; 43(1):44-51. PubMed ID: 29215423
[TBL] [Abstract][Full Text] [Related]
4. Galactosemia: when is it a newborn screening emergency?
Berry GT
Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
[TBL] [Abstract][Full Text] [Related]
5. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient.
Schulpis KH; Thodi G; Chatzidaki M; Iakovou K; Molou E; Dotsikas Y; Loukas YL
J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1119-1120. PubMed ID: 28902631
[No Abstract] [Full Text] [Related]
6. Hereditary galactosemia.
Demirbas D; Coelho AI; Rubio-Gozalbo ME; Berry GT
Metabolism; 2018 Jun; 83():188-196. PubMed ID: 29409891
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of inherited disorders of galactose metabolism.
Cuthbert C; Klapper H; Elsas L
Curr Protoc Hum Genet; 2008 Jan; Chapter 17():Unit 17.5. PubMed ID: 18428423
[TBL] [Abstract][Full Text] [Related]
8. Addition of galactose-1-phosphate measurement enhances newborn screening for classical galactosemia.
Daas S; Abu Salah N; Anikster Y; Barel O; Damseh NS; Dumin E; Fattal-Valevski A; Falik-Zaccai TC; Habib C; Josefsberg S; Korman SH; Kneller K; Landau Y; Lerman-Sagie T; Mandel H; Manor Y; Moady Abdalla T; Rock R; Rostami N; Saada A; Saraf-Levy T; Shaul Lotan N; Spiegel R; Staretz-Chacham O; Tal G; Ulanovsky I; Vaisid T; Wilnai Y; Almashanu S
J Inherit Metab Dis; 2023 Mar; 46(2):232-242. PubMed ID: 36515074
[TBL] [Abstract][Full Text] [Related]
9. Nine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes.
Welling L; Boelen A; Derks TG; Schielen PC; de Vries M; Williams M; Wijburg FA; Bosch AM
Mol Genet Metab; 2017 Mar; 120(3):223-228. PubMed ID: 28065439
[TBL] [Abstract][Full Text] [Related]
10. Novel Mutation in GALT Gene in Galactosemia Patient with Group B Streptococcus Meningitis and Acute Liver Failure.
Grama A; Blaga L; Nicolescu A; Deleanu C; Militaru M; Căinap SS; Pop I; Tita G; Sîrbe C; Fufezan O; Vințan MA; Vulturar R; Pop TL
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987402
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile and molecular characterization of Galactosemia in Brazil: identification of seven novel mutations.
Garcia DF; Camelo JS; Molfetta GA; Turcato M; Souza CF; Porta G; Steiner CE; Silva WA
BMC Med Genet; 2016 May; 17(1):39. PubMed ID: 27176039
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach.
Freer DE; Ficicioglu C; Finegold D
Clin Chem; 2010 Mar; 56(3):437-44. PubMed ID: 20075179
[TBL] [Abstract][Full Text] [Related]
13. Coordinated movement, neuromuscular synaptogenesis and trans-synaptic signaling defects in Drosophila galactosemia models.
Jumbo-Lucioni PP; Parkinson WM; Kopke DL; Broadie K
Hum Mol Genet; 2016 Sep; 25(17):3699-3714. PubMed ID: 27466186
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.
Haskovic M; Coelho AI; Bierau J; Vanoevelen JM; Steinbusch LKM; Zimmermann LJI; Villamor-Martinez E; Berry GT; Rubio-Gozalbo ME
J Inherit Metab Dis; 2020 May; 43(3):392-408. PubMed ID: 31808946
[TBL] [Abstract][Full Text] [Related]
15. [Galactose-1-phosphate uridyltransferase deficiency].
Okano Y; Isshiki G
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):15-21. PubMed ID: 9589977
[No Abstract] [Full Text] [Related]
16. The natural history of classic galactosemia: lessons from the GalNet registry.
Rubio-Gozalbo ME; Haskovic M; Bosch AM; Burnyte B; Coelho AI; Cassiman D; Couce ML; Dawson C; Demirbas D; Derks T; Eyskens F; Forga MT; Grunewald S; Häberle J; Hochuli M; Hubert A; Huidekoper HH; Janeiro P; Kotzka J; Knerr I; Labrune P; Landau YE; Langendonk JG; Möslinger D; Müller-Wieland D; Murphy E; Õunap K; Ramadza D; Rivera IA; Scholl-Buergi S; Stepien KM; Thijs A; Tran C; Vara R; Visser G; Vos R; de Vries M; Waisbren SE; Welsink-Karssies MM; Wortmann SB; Gautschi M; Treacy EP; Berry GT
Orphanet J Rare Dis; 2019 Apr; 14(1):86. PubMed ID: 31029175
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy: structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene.
Viggiano E; Marabotti A; Burlina AP; Cazzorla C; D'Apice MR; Giordano L; Fasan I; Novelli G; Facchiano A; Burlina AB
Gene; 2015 Apr; 559(2):112-8. PubMed ID: 25592817
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of galactosemia - Past, present and future.
Timson DJ
Gene; 2016 Sep; 589(2):133-41. PubMed ID: 26143117
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the screening programme for galactosemia. New strategy in Poland.
Radomyska B
Med Wieku Rozwoj; 2001; 5(1):51-8. PubMed ID: 11276504
[TBL] [Abstract][Full Text] [Related]
20. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia.
Daenzer JMI; Rasmussen SA; Patel S; McKenna J; Fridovich-Keil JL
J Inherit Metab Dis; 2022 Mar; 45(2):203-214. PubMed ID: 34964137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
